Section Arrow
Quote
RNA.NASDAQ
- Atrium Therapeutics Inc.
Quotes are at least 15-min delayed:2026/04/07 18:26 EDT
After Hours
Last
 13.3339
-0.6561 (-4.69%)
Bid
13.99
Ask
14.51
High 13.99 
Low 13.3339 
Volume 817 
Regular Hours (Closed)
Last
 13.99
+0.32 (+2.34%)
Day High 
13.995 
Prev. Close
13.67 
1-M High
15.84 
Volume 
234.90K 
Bid
13.99
Ask
14.51
Day Low
13.555 
Open
13.61 
1-M Low
11.95 
Market Cap 
212.09M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 13.33 
20-SMA 13.58 
50-SMA -- 
52-W High 16.77 
52-W Low 11.95 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.48/-2.78
Enterprise Value
212.09M
Balance Sheet
Book Value Per Share
13.36
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
18.76M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QNCXQuince Therapeutics0.163+0.0755+86.29%-- 
After Hours 0.2309 +0.0679 +41.66%
SILOSilo Pharma0.5302+0.1744+49.02%-- 
After Hours 0.5007 -0.0295 -5.56%
LNAILunai Bioworks Inc.0.3941+0.1121+39.75%-- 
After Hours 0.4085 +0.0144 +3.65%
CUECue Biopharma0.1882+0.0112+6.33%-- 
After Hours 0.1832 -0.005 -2.66%
TERNTerns Pharmaceuticals52.62-0.16-0.30%-- 
After Hours 52.79 +0.17 +0.32%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.